本文選題：醫(yī)藥制造業(yè) + 技術(shù)創(chuàng)新投入�。� 參考：《遼寧大學(xué)》2015年碩士論文

【摘要】：從改革開(kāi)放以來(lái),我國(guó)醫(yī)藥制造業(yè)發(fā)展迅速,對(duì)醫(yī)藥制造業(yè)技術(shù)創(chuàng)新能力對(duì)產(chǎn)出績(jī)效的研究已經(jīng)較為豐富,研究的內(nèi)容和領(lǐng)域正向不斷的深化。但是我國(guó)醫(yī)藥制造業(yè)存在著子行業(yè)發(fā)展不均衡、區(qū)域發(fā)展不均衡的情況,因此本文從子行業(yè)、區(qū)域兩個(gè)視角著手,研究醫(yī)藥制造業(yè)各個(gè)子行業(yè)、區(qū)域間技術(shù)創(chuàng)新投入對(duì)產(chǎn)出績(jī)效的不同影響。文章首先闡述以往學(xué)者相關(guān)的研究綜述與基本理論,為后文合理評(píng)價(jià)和選擇衡量指標(biāo)、方法提供依據(jù),進(jìn)而對(duì)醫(yī)藥制造行業(yè)進(jìn)行界定、描述子行業(yè)、區(qū)域的發(fā)展現(xiàn)狀,將醫(yī)藥制造業(yè)整體行業(yè)劃分為化學(xué)藥品制造、生物制藥、中成藥,按照區(qū)域劃分為東部、中部和西部,構(gòu)建理論模型,對(duì)子行業(yè)、各區(qū)域的投入產(chǎn)出指標(biāo)進(jìn)行描述性分析、相關(guān)性分析、借助知識(shí)生產(chǎn)函數(shù),運(yùn)用逐步回歸的方法對(duì)每一子行業(yè)和區(qū)域進(jìn)行實(shí)證分析,對(duì)比得出子行業(yè)、區(qū)域間的差異,進(jìn)而得出本文的結(jié)論并給出政策建議。通過(guò)實(shí)證分析本文得出結(jié)論,化學(xué)制藥行業(yè)、生物制藥行業(yè)、中成藥行業(yè)與東部地區(qū)、中部地區(qū)、西部地區(qū)三個(gè)區(qū)域技術(shù)創(chuàng)新投入與產(chǎn)出情況存在差異,與此同時(shí),影響化學(xué)制藥行業(yè)、生物制藥行業(yè)、中成藥行業(yè)、以及東部地區(qū)、中部地區(qū)、西部地區(qū)三個(gè)區(qū)域醫(yī)藥制造業(yè)技術(shù)創(chuàng)新投入對(duì)產(chǎn)出績(jī)效影響的因素各不相同。經(jīng)過(guò)實(shí)證本文得出這樣的發(fā)現(xiàn),盡管化學(xué)制藥行業(yè)是醫(yī)藥制造業(yè)的典型行業(yè),化學(xué)藥品制造業(yè)消化吸收比重對(duì)產(chǎn)出績(jī)效的影響與醫(yī)藥制造業(yè)整體消化吸收對(duì)產(chǎn)出績(jī)效的作用程度是不同的;經(jīng)過(guò)區(qū)域的對(duì)比發(fā)現(xiàn),西部地區(qū)技術(shù)引進(jìn)對(duì)產(chǎn)出績(jī)效的作用、東部地區(qū)技術(shù)改造對(duì)產(chǎn)出績(jī)效的作用彈性與全國(guó)醫(yī)藥制造業(yè)整體的情況也呈現(xiàn)相反的作用。其次,化學(xué)制藥行業(yè)、生物制藥行業(yè)、中成藥行業(yè)、以及東部地區(qū)、中部地區(qū)、西部地區(qū)三個(gè)區(qū)域,影響其產(chǎn)出績(jī)效的顯著因素不盡相同。最后,根據(jù)前文的實(shí)證部分結(jié)論,對(duì)比醫(yī)藥制造業(yè)中化學(xué)制藥行業(yè)、中成藥生產(chǎn)行業(yè)、生物藥品制造業(yè)之間差異以及東部、中部、西部地區(qū)之間的差異,從行業(yè)、區(qū)域的角度為醫(yī)藥制造業(yè)行業(yè)間、區(qū)域間技術(shù)創(chuàng)新活動(dòng)協(xié)調(diào)發(fā)展提供對(duì)策。
[Abstract]:Since the reform and opening up, the pharmaceutical manufacturing industry in China has developed rapidly. The research on the technological innovation ability of the pharmaceutical manufacturing industry to the output performance has been relatively rich, and the contents and fields of the research are constantly deepening.However, there is imbalance in the development of sub-industry and regional development in Chinese pharmaceutical manufacturing industry. Therefore, this paper starts with sub-industry and regional perspective, and studies each sub-industry of pharmaceutical manufacturing industry.Different effects of interregional technological innovation input on output performance.The article first describes the previous scholars related to the review and basic theory, for the following reasonable evaluation and selection of measurement indicators, methods to provide the basis, and then to define the pharmaceutical manufacturing industry, describe the development of sub-industry, regional development.The whole industry of pharmaceutical manufacturing is divided into chemical manufacturing, biopharmaceutical, Chinese patent medicine, and divided into the east, middle and west according to the region. The theoretical model is constructed, and the input-output index of the sub-industry and each region is analyzed in a descriptive way.Correlation analysis, with the help of knowledge production function, using the method of stepwise regression for each sub-industry and regional empirical analysis, the comparison of sub-industries, regional differences, and then draw the conclusion of this paper and give policy recommendations.Through the empirical analysis, the paper draws the conclusion that there are differences in the input and output of technological innovation between the chemical pharmaceutical industry, the biopharmaceutical industry, the Chinese patent medicine industry and the eastern, central and western regions, at the same time,The factors that affect the output performance of the three regions are different: chemical pharmaceutical industry, biopharmaceutical industry, Chinese patent medicine industry, as well as the three regions of the eastern region, the central region and the western region.The empirical results of this paper show that although the chemical pharmaceutical industry is a typical industry in the pharmaceutical manufacturing industry,The effect of the proportion of digestion and absorption on the output performance of chemical manufacturing industry is different from that of the pharmaceutical manufacturing industry as a whole, and the regional comparison shows that the technology introduction in the western region plays an important role in the output performance.The elasticity of technological transformation on output performance in eastern China is opposite to that of the whole pharmaceutical manufacturing industry in China.Secondly, chemical pharmaceutical industry, biopharmaceutical industry, Chinese patent medicine industry, as well as the eastern, central and western regions, the significant factors affecting their output performance are different.Finally, according to the empirical conclusions above, the differences among the chemical pharmaceutical industry, the Chinese patent medicine industry, the biological medicine manufacturing industry and the eastern, central and western regions are compared.The regional perspective provides countermeasures for the coordinated development of technological innovation activities in the pharmaceutical manufacturing industry.
【學(xué)位授予單位】：遼寧大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2015
【分類(lèi)號(hào)】：F426.72;F273.1

【參考文獻(xiàn)】

相關(guān)期刊論文 前5條

1 劉秉鐮;徐鋒;李蘭冰;;中國(guó)醫(yī)藥制造業(yè)創(chuàng)新效率評(píng)價(jià)與要素效率解構(gòu)[J];管理世界;2013年02期

2 陳紅川;;醫(yī)藥制造業(yè)技術(shù)創(chuàng)新能力評(píng)價(jià)實(shí)證研究[J];廣州大學(xué)學(xué)報(bào)(自然科學(xué)版);2013年04期

3 孫虹;俞會(huì)新;;河北省醫(yī)藥制造業(yè)技術(shù)創(chuàng)新效率及創(chuàng)新能力研究[J];科技管理研究;2012年10期

4 陳鈺芬;;企業(yè)開(kāi)放式創(chuàng)新的動(dòng)態(tài)模式研究[J];科研管理;2009年05期

5 閻海峰;程鵬;;吸收能力研究評(píng)述[J];管理評(píng)論;2009年08期

，

本文編號(hào)：1734565